Investigators build a better targeted drug therapy using the power of computation

Antibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy cancerous tissue while leaving healthy cells intact—represent a long sought-after advancement in cancer therapy. ADCs work by attaching a cancer drug to an antibody that is unique to a specific type of tissue, allowing ADCs to deliver treatment directly to the site of a tumor rather than throughout the body.

From http://besthealthnews.com/2019/11/investigators-build-a-better-targeted-drug-therapy-using-the-power-of-computation/?utm_source=rss&utm_medium=rss&utm_campaign=investigators-build-a-better-targeted-drug-therapy-using-the-power-of-computation

from
https://healthnews010.wordpress.com/2019/11/09/investigators-build-a-better-targeted-drug-therapy-using-the-power-of-computation/

From https://jamesjohnson10.blogspot.com/2019/11/investigators-build-better-targeted.html

from
https://jamesjohnson10.wordpress.com/2019/11/09/investigators-build-a-better-targeted-drug-therapy-using-the-power-of-computation/